PREDICTING OPIOID THERAPY SAFETY IN PANCREATIC CANCER PATIENTS ArticleBobrova O.P., Zyryanov S.K., Shnayder N.A., Petrova M.M.Russian Open Medical Journal. Vol. 9. 2021.
DETECTING MEDICATION ERRORS ASSOCIATED WITH THE USE OF BETA-LACTAMS IN THE RUSSIAN PHARMACOVIGILANCE DATABASE ArticleKuzmina A.V., Asetskaya I.L., Zyryanov S.K., Polivanov V.A.BMC Pharmacology and Toxicology. Vol. 22. 2021.
EVOLUTIONARY ALGORITHM FOR AUTOMATED FORMATION OF DECISION-MAKING MODELS FOR PREDICTING THE SAFETY OF OPIOID THERAPY ArticleLipinskiy L.V., Melnikova O.D., Polyakova A.S., Evseeva S.A., Bobrova O.P., Shnayder N.A., Zyryanov S.K., Petrova M.M., Dychno Y.A., Zobova S.N., Bobrov A.V.IOP Conference Series: Materials Science and Engineering. Vol. 1047. 2021.
COMPARATIVE GENOME ANALYSIS OF GLOBAL AND RUSSIAN STRAINS OF COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS ST22, A ‘GAZA CLONE’ ArticleGostev V., Ivanova K., Kruglov A., Kalinogorskaya O., Ryabchenko I., Zyryanov S., Kalisnikova E., Likholetova D., Lobzin Y., Sidorenko S.International Journal of Antimicrobial Agents. Vol. 57. 2021.
MULTIVARIABLE ANALYSIS OF PRIMARY CARE PHYSICIAN ADHERENCE TO GUIDELINE-RECOMMENDED PHARMACOTHERAPY OF STABLE CORONARY ARTERY DISEASE ArticleZyryanov S.K., Fitilev S.B., Vozzhaev A.V., Shkrebniova I.I.Rational Pharmacotherapy in Cardiology. Vol. 17. 2021. P.. 29-35
CLINICAL AND ECONOMIC COMPARISON OF UTILIZATION OF RESLIZUMAB, MEPOLIZUMAB AND BENRALIZUMAB IN THE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA ArticleZyryanov S.K., Avdeev S.N., Ivanov D.A., Zhuravleva M.V., Kniajeskaia N.P., Matveev N.V., Nenasheva N.A., Fomina D.S., Frolov M.Iu.Terapevticheskii Arkhiv. Vol. 92. 2021. P.. 172-179
TOPICAL GLUCOCORTICOSTEROIDS: EFFICACY AND SAFETY IN GYNECOLOGY ArticleZyryanov S.K., Butranova O.I.Akusherstvo i Ginekologiya. Vol. 2021. 2021. P.. 166-172
EXPERT COUNCIL RESOLUTION ON THE INTERMEDIATE RESULTS OF STATISTICAL STUDY «EFFECTIVENESS OF A FIXED COMBINATION OF ORPHENADRINE AND DICLOFENAC IN PATIENTS WITH ACUTE BACK AND NECK PAIN» ArticleKukushkin M.L., Amelin A.V., Zyryanov S.K., Balyazin V.A., Shirokov V.A., Medvedeva L.A., Akhmadeeva L.R., Kurushina O.V., Kiselev D.V., Abuzarova G.R., Davydov O.S.Российский журнал боли. Vol. 19. 2021. P.. 60-62
CALCULATING INDIRECT COSTS ASSOCIATED WITH MODERATE AND SEVERE PSORIASIS IN RUSSIA ArticleNovoderezhkina E., Zyryanov S.Value in Health. Vol. 24. 2021.
ADHERENCE TO MEDICAL TREATMENT IN ELDERLY PATIENTS WITH CORONARY ARTERY DISEASE IN THE SETTINGS OF PRIMARY OUTPATIENT CARE ArticleZyryanov S.K., Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Shindryaeva N.N., Klyuev D.A., Stepanyan L.N., Lutsenko A.M., Tsai A.T., Danilova A.A.Rational Pharmacotherapy in Cardiology. Vol. 17. 2021. P.. 178-185
INFUSION FLUIDS: A CLINICAL PHARMACOLOGIST’S VIEW ArticleUshkalova E.A., Zyryanov S.K., Zatolochina K.E., Butranova O.I.Анестезиология и реаниматология. Vol. 2021. 2021. P.. 100-106
ISATUXIMAB, A NOVEL ANTI-CD38 MONOCLONAL ANTIBODY IN THE TREATMENT OF MULTIPLE MYELOMA: EFFICACY AND SAFETY [НОВОЕ МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К CD38 ИЗАТУКСИМАБ В ТЕРАПИИ МНОЖЕСТВЕННОЙ МИЕЛОМЫ: ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ] ArticleZatolochina K.E., Zyryanov S.K., Ushkalova E.A.Современная онкология. Vol. 23. 2021. P.. 327-331
MANAGEMENT OF ADHERENCE-BASED TREATMENT. CONSENSUS DOCUMENT – CLINICAL GUIDELINES. ENGLISH VERSION ArticleNikolaev N.A., Martynov A.I., Skirdenko Yu.P., Anisimov V.N., Vasilieva I.A., Vinogradov O.I., Lazebnik L.B., Poddubnaya I.V., Roitman E.V., Ageev F.T., Andreev K.A., Babicheva L.G., Bunova S.S., Viktorova I.A., Volchegorskiy I.A., Galyavich A.S., Gaus O.V., Gomberg V.G., Gorbenko A.V., Drapkina O.M. ...Medical News of North Caucasus. Vol. 16. 2021. P.. 125-134
PERAMPANEL IN THE ADDITIONAL THERAPY OF FOCAL AND PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN CHILDREN 4–12 YEARS OLD: CLINICAL DATA, EXPERIENCE OF USE AND PRACTICAL RECOMMENDATIONS ArticleMukhin K.Yu., Belousova E.D., Burd S.G., Barkhatov M.V., Ermolenko N.А., Zyryanov S.К., Karpovich E.I., Morozova E.А., Odintsova G.V.Эпилепсия и пароксизмальные состояния. Vol. 13. 2021. P.. 180-187
PREDICTING OF FENTANYL-ASSOCIATED NEUROTOXICITY IN PANCREATIC CANCER WITH CLICAL, GENETIC MODEL [ПРОГНОЗИРОВАНИЕ ФЕНТАНИЛ-АССОЦИИРОВАННОЙ НЕЙРОТОКСИЧНОСТИ У БОЛЬНЫХ С РАКОМ ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ С ПОМОЩЬЮ КЛИНИКО-ГЕНЕТИЧЕСКОЙ МОДЕЛИ] ArticleBobrova O.P., Shnayder N.A., Petrova M.M., Zobova S.N., Dykhno Y.A., Zyryanov S.K., Bobrov A.V., Nasyrova R.F., Lipinsky L.V., Polyakova A.S., Melnikova O.D.Экспериментальная и клиническая гастроэнтерология. Vol. 187. 2021. P.. 136-145